At Ascenthera, we believe that innovation in healthcare is the driving force for developing and delivering better and cost-efficient diagnostic and treatment options. We apply value-focused innovation from the design and development, to the delivery of Advanced Therapeutic Solutions (integrated products and solutions) across therapeutic areas.
We leverage our proprietary AMVRx knowledge and technology platform to design and develop Advanced Therapeutic Solutions that target the disease/health conditions at multiple fronts, viz., (i) by effectively modulating the biological pathways/molecular signaling systems associated with the pathophysiology of the disease condition; and (ii) by addressing the metabolic imbalances associated with the disease condition, thereby providing highly effective treatment approach and continuum of care.
Our Advanced Therapeutic Solutions consist of innovative prescription (Rx), consumer healthcare (CHC), advanced metabolic therapeutic (Rx-MT), and diagnostic (Dx) products that are tailored to effectively diagnose, treat, and prevent diseases. These products and solutions target across the spectrum of subclinical, clinical, and complications of the disease.
Value of Advanced Therapeutic Solutions for Patients:
The value of our Advanced Therapeutic Solutions is focused on providing better care and value to healthcare seekers by: (i) improving the clinical outcome for patients and their overall quality of life; (ii) offering smarter treatment choices with significant benefits over the existing options; and (iii) reducing overall healthcare costs.
Value of Advanced Therapeutic Solutions for Healthcare Professionals and Providers:
Advanced Therapeutic Solutions include some of the customized point-of-care solutions to HCPs (healthcare professionals and/or healthcare providers) that enable them to: (i) improve clinical outcome for their patients: (ii) customize the treatment depending on patient’s clinical situation; (iii) provide better care and value to their patients; (iv) improve their patients’ compliance and convenience; and (v) enhance HCP’s revenue.